Mindpeak says AI in pathology depends on workflow integration

Mindpeak is using ECP 2026 to argue that digital pathology AI only works in daily lab practice when it fits existing workflows, validation steps and viewer software. The company’s collaboration with Leica Biosystems puts six algorithms inside a single digital pathology environment.

Why it matters: - Digital pathology AI can speed biomarker quantification and tissue analysis, but laboratories need tools that fit existing systems. - Workflow integration can reduce steps between slide review and results. - Reliable deployment matters because labs need validation, consistent results and user confidence before AI becomes routine.

What happened: - Mindpeak is highlighting practical requirements for AI adoption in digital pathology at ECP 2026 in a session framed around "Innovation Driving Excellence in Pathology." - Mindpeak and Leica Biosystems have made six Mindpeak algorithms available through the Leica Biosystems Aperio AI Store. - The six algorithms include Mindpeak’s Breast suite, Pan-Tumor H&E and Pan-Tumor PD-L1. - The algorithms can be launched inside the Aperio HALO AP software environment. - The setup gives users access inside a single viewer already used in the digital pathology workflow.

The details: - Mindpeak says integration in pathology goes beyond connecting two software products. - Metadata, slide overlays, result presentation and validation requirements all have to work consistently for a laboratory deployment. - The company says these operational details are central to how reliably an AI solution performs in the lab. - Mindpeak positions the collaboration with Leica Biosystems as an example of building an ecosystem where AI developers and platform providers work inside established laboratory environments. - Mindpeak CEO Felix Faber said a strong algorithm is only one part of solving a pathology problem, and deployment context matters. - Leica Biosystems digital pathology chief Naveen Chandra said the value of AI appears when pathologists can access the right tools at the right time without moving between multiple systems. - Chandra said the Aperio AI Store and Aperio HALO AP connect AI innovations within a single workflow to improve efficiency, confidence and patient care. - Mindpeak was founded in 2018 and focuses on AI-powered digital pathology. - Mindpeak says its technology helps laboratories extract insights from H&E, IHC and mIF tissue images. - The company says its tools range from subcellular biomarker quantification to predictive patient stratification. - Mindpeak says the solutions support routine diagnostics and the translation of novel biomarkers into clinical applications. - More information is available at Mindpeak’s website.

Between the lines: - The announcement is less about a new algorithm and more about making AI usable in the real laboratory setting. - Mindpeak is signaling that adoption will depend on interoperability, not just model performance. - The Leica partnership also shows how AI vendors may need platform partners to move from standalone products to embedded workflow tools.

What’s next: - Mindpeak is using ECP 2026 to push the view that validation, deployment and workflow fit will shape AI adoption in pathology. - The company and Leica Biosystems are positioning integrated AI access as a template for broader clinical use. - Pathology teams will likely focus on whether these integrated tools can be validated and scaled without adding complexity.